Relapsing Polychondritis Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Relapsing Polychondritis
Relapsing polychondritis (RP) is a rare and often challenging autoimmune disorder causing inflammation and damage to cartilage throughout the body. Its unpredictable nature makes diagnosis and management complex. For those living with RP, treatment can be costly, but TheDrugClub offers a straightforward way to save on necessary medications, making ongoing care more accessible and manageable.
Relapsing polychondritis (RP) is a systemic autoimmune condition characterized by recurrent episodes of inflammation that target cartilage and other proteoglycan-rich tissues. While relatively rare, affecting roughly 3-5 people per million, its impact can be significant. RP can affect almost any cartilaginous structure in the body, most notably the ears, nose, and joints, but also more critical areas like the trachea, larynx, and heart valves. Inflammation in these areas can lead to pain, swelling, redness, and eventually, irreversible damage or collapse of the affected structures.
Symptoms vary widely among individuals but often include painful, red, and swollen ears (sparing the earlobe), nasal cartilage inflammation leading to a 'saddle nose' deformity, and joint pain similar to arthritis. More serious manifestations can involve the respiratory tract, causing breathing difficulties; the eyes, leading to vision problems; and the cardiovascular system, potentially impacting heart valve function. Diagnosis can be difficult due to RP's rarity and varied presentation, often relying on clinical criteria and sometimes a biopsy of affected cartilage.
Managing relapsing polychondritis focuses on reducing inflammation during flares and preventing further cartilage damage. There is currently no cure, so treatment aims to control symptoms and preserve organ function. The primary medications used are corticosteroids, such as prednisone, which are effective in controlling inflammation. For patients who require high doses of steroids or experience frequent relapses, immunosuppressants like methotrexate
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.